-
M650540-25mgMC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. MC-Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 ( HY-13631 ) and a cathepsin cleavable ADC linker .In VitroADCs are comprised of an antibody to
-
M650540-5mgMC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. MC-Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 ( HY-13631 ) and a cathepsin cleavable ADC linker .In VitroADCs are comprised of an antibody to
-
M658710-1mgMc-Val-Cit-PAB-Gefitinib chloride is a agent-linker conjugates for ADC . Mc-Val-Cit-PAB-Gefitinib chloride consists of Gefitinib ( HY-50895 ) (an EGFR tyrosine kinase inhibitor) and the ADC linker Mc-Val-Cit-PAB.Appearance:SolidBiological
-
M651684-100mgMC-Val-Cit-PAB-Indibulin is a agent-linker conjugate for ADC with potent antitumor activity by using Indibulin (an orally applicable inhibitor of tubulin assembly), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: Target:Traditional
-
M651684-10mgMC-Val-Cit-PAB-Indibulin is a agent-linker conjugate for ADC with potent antitumor activity by using Indibulin (an orally applicable inhibitor of tubulin assembly), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: Target:Traditional
-
M651684-25mgMC-Val-Cit-PAB-Indibulin is a agent-linker conjugate for ADC with potent antitumor activity by using Indibulin (an orally applicable inhibitor of tubulin assembly), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: Target:Traditional
-
M651684-50mgMC-Val-Cit-PAB-Indibulin is a agent-linker conjugate for ADC with potent antitumor activity by using Indibulin (an orally applicable inhibitor of tubulin assembly), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: Target:Traditional
-
M651684-5mgMC-Val-Cit-PAB-Indibulin is a agent-linker conjugate for ADC with potent antitumor activity by using Indibulin (an orally applicable inhibitor of tubulin assembly), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: Target:Traditional
-
M651711-10mgMC-Val-Cit-PAB-MMAF (Vc-MMAF) is a agent-linker conjugate for ADC by using the tubulin inhibitor, MMAF, linked via cathepsin cleavable MC-Val-Cit-PAB. MC-Val-Cit-PAB-MMAF shows antitumor activityForm:SolidIC50&: Target:Auristatin.
-
M651711-1mgMC-Val-Cit-PAB-MMAF (Vc-MMAF) is a agent-linker conjugate for ADC by using the tubulin inhibitor, MMAF, linked via cathepsin cleavable MC-Val-Cit-PAB. MC-Val-Cit-PAB-MMAF shows antitumor activityForm:SolidIC50&: Target:Auristatin.
-
M651711-25mgMC-Val-Cit-PAB-MMAF (Vc-MMAF) is a agent-linker conjugate for ADC by using the tubulin inhibitor, MMAF, linked via cathepsin cleavable MC-Val-Cit-PAB. MC-Val-Cit-PAB-MMAF shows antitumor activityForm:SolidIC50&: Target:Auristatin.
-
M651711-5mgMC-Val-Cit-PAB-MMAF (Vc-MMAF) is a agent-linker conjugate for ADC by using the tubulin inhibitor, MMAF, linked via cathepsin cleavable MC-Val-Cit-PAB. MC-Val-Cit-PAB-MMAF shows antitumor activityForm:SolidIC50&: Target:Auristatin.